We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App




Advanced Hematology Analyzer Brings Simplicity and Efficiency to Decentralized Healthcare Facilities

By LabMedica International staff writers
Posted on 02 Jan 2023
Print article
Image: The Aquarius 3 three part differential IVD hematology analyzer for Complete Blood Count testing (Photo courtesy of Diatron)
Image: The Aquarius 3 three part differential IVD hematology analyzer for Complete Blood Count testing (Photo courtesy of Diatron)

A new hematology analyzer is all set to bring unrivaled simplicity and efficiency to the decentralized market segment.

Diatron (Budapest, Hungary) has announced the launch of Aquarius 3, its latest IVD hematology analyzer for Complete Blood Count testing. Aquarius 3 will be the first in a new family of hematology analyzers from Diatron. Evolving from the Abacus 380, Diatron’s flagship analyzer, the Aquarius 3 incorporates similar robust and trusted counting technology but is equipped with new features to improve operability and connectivity, allowing it to adapt to diverse environments for the benefit of both customers and users alike.

While still retaining the important features of the Abacus 380, the Aquarius 3 has many other product enhancements, with the most obvious change being the addition of an 8” high resolution, color touch screen, making it clear and simple to operate. Other features include 1D/2D barcode scanner for sample ID, QC and reagent management (closed system), 25 μl sampling volume, including micro‐tube capability, increased database capacity with 10,000 + USB mass storage, and a wider choice of external printers. In line with its predecessors, the new Aquarius 3 is easy to use, flexible and suitable for a variety uses such as in doctor’s offices, low to mid‐size laboratories and other decentralized healthcare facilities.

Related Links:
Diatron 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.